MTOR and breast carcinoma: However, the antiproliferative mechanisms of metformin remain undetermined, with several studies having suggested that metformin achieves its antiproliferative mechanism in breast cancer cells via inducing cellular apoptosis by regulating the AMPK/mTOR signaling pathway [23,78].